Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concentration-Controlled Ribavirin in Chronic HCV
NCT01097395Phase 4Completed
- Sponsor
- University of Colorado Denver
- Start
- Feb 2010
- Primary completion
- Aug 2015
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of ribavirin in hepatitis C (HCV), sponsored by University of Colorado Denver. Started Feb 2010; status: completed.
02
Drugs
ribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01097395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01097395.